|
Jan 10
|
Moderna (MRNA) Stock Drops Despite Market Gains: Important Facts to Note
|
|
Jan 10
|
Investors in Moderna (NASDAQ:MRNA) have seen enviable returns of 578% over the past five years
|
|
Jan 10
|
Your Path to Wealth: 3 Stocks Predicted to Double Your Investment by 2025
|
|
Jan 9
|
2024 Marks a New Era Of Pharmaceutical Innovation
|
|
Jan 9
|
Moderna (MRNA) Issues 2023 Preliminary Results, Stock Up 4%
|
|
Jan 9
|
7 S&P 500 Stocks to Buy to Keep the Bull Market Running
|
|
Dec 23
|
20 Best Countries for Doctors to Immigrate to
|
|
Dec 21
|
What to Know About the New Fast-Spreading Covid-19 Strain
|
|
Dec 21
|
Biotech Stock Roundup: CGEN Up on GILD Deal, MRNA Gains on Study Data & More
|
|
Dec 20
|
Moderna to Present at the 42nd Annual J.P. Morgan Healthcare Conference
|
|
Dec 20
|
12 Most Promising Gene Editing Stocks According to Hedge Funds
|
|
Dec 20
|
Is It Time to Buy the S&P 500's 4 Worst-Performing Stocks This Year?
|
|
Dec 18
|
Picking Through the Rubble of This Year's Hardest-Hit Stocks
|
|
Dec 18
|
Why Investors Shouldn't Be Surprised By Moderna, Inc.'s (NASDAQ:MRNA) Low P/S
|
|
Dec 18
|
3 Stocks Down 30% or More This Year That Wall Street Expects to Skyrocket in 2024
|
|
Dec 18
|
Moderna Just Took a Step Closer to Its Product Launch Goal. Is the Stock a Buy?
|
|
Dec 7
|
Why Is Iovance Biotherapeutics (IOVA) Up 53% Since Last Earnings Report?
|
|
Dec 7
|
Recent uptick might appease Moderna, Inc. (NASDAQ:MRNA) institutional owners after losing 55% over the past year
|
|
Dec 7
|
Moderna Reviews its Environmental, Social and Governance (ESG) Progress and Ambitions at Second ESG Investor Event
|
|
Dec 6
|
CRISPR Therapeutics AG (CRSP) Up 20.5% Since Last Earnings Report: Can It Continue?
|